Sequential assessments of KRAS-mutated circulating tumor DNA in longitudinal monitoring enable the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.

被引:1
|
作者
Watanabe, Fumiaki
Suzuki, Koichi
Tamaki, Sawako
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
关键词
D O I
10.1200/JCO.2019.37.15_suppl.e15712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15712
引用
收藏
页数:1
相关论文
共 50 条
  • [31] INDIVIDUALISED MEASUREMENT OF TUMOUR-DERIVED CIRCULATING DNA IN PATIENTS WITH PANCREATIC CANCER: A MARKER OF PROGNOSIS AND THERAPEUTIC RESPONSE
    Chin, V. T.
    Waddell, N.
    Nones, K.
    Quek, K.
    Mawson, A.
    Johns, A.
    Grimmond, S.
    Biankin, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 36 - 36
  • [32] Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer
    He, Wan
    Yang, Jingxin
    Sun, Xiao
    Jiang, Shunda
    Jiang, Jinchan
    Liu, Ming
    Mu, Tianhao
    Li, Yingmei
    Zhang, Xiaoni
    Duan, Jingxian
    Xu, Ruilian
    BIOMARKER INSIGHTS, 2022, 17
  • [33] Circulating tumor DNA analysis to detect minimal residual disease and predict recurrence in patients with resectable pancreatic cancer.
    Yang, Liu
    Jiang, Jiahong
    Ye, Song
    Xu, Yaping
    Huang, Dongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Kras Gene Analysis Using Liquid-Based Cytology Specimens Predicts Therapeutic Responses and Prognosis in Patients with Pancreatic Cancer
    Itonaga, Masahiro
    Ashida, Reiko
    Murata, Shin-Ichi
    Yamashita, Yasunobu
    Hatamaru, Keiichi
    Tamura, Takashi
    Kawaji, Yuki
    Kayama, Yuudai
    Emori, Tomoya
    Kawai, Manabu
    Yamaue, Hiroki
    Matsuzaki, Ibu
    Nagai, Hirokazu
    Kinoshita, Yuichi
    Wan, Ke
    Shimokawa, Toshio
    Kitano, Masayuki
    CANCERS, 2022, 14 (03)
  • [35] Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response.
    Zhou, Jianfeng
    Jia, Ning
    Sun, Zhao
    Gao, Xin
    Cheng, Yuejuan
    Chen, Wei
    Shen, Chunying
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [36] Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK plus Lung Cancer
    Horn, Leora
    Whisenant, Jennifer G.
    Wakelee, Heather
    Reckamp, Karen L.
    Qiao, Huan
    Leal, Ticiana A.
    Du, Liping
    Hernandez, Jennifer
    Huang, Vincent
    Blumenschein, George R.
    Waqar, Saiama N.
    Patel, Sandip P.
    Nieva, Jorge
    Oxnard, Geoffrey R.
    Sanborn, Rachel E.
    Shaffer, Tristan
    Garg, Kavita
    Holzhausen, Allison
    Harrow, Kimberly
    Liang, Chris
    Lim, Lee P.
    Li, Mark
    Lovly, Christine M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : 1901 - 1911
  • [37] Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.
    Wang, Xiuchao
    Wang, Hongwei
    Chen, Xinyun
    Liu, Yuxiao
    Zhao, Tiansuo
    Gao, Song
    Wang, Jian
    Ma, Weidong
    Gao, Chuntao
    Hao, Jihui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 744 - 744
  • [38] Comparative levels of KRAS mutations circulating tumor DNA for association with overall survival in patients with non-resectable pancreatic cancer
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Hassaine, Latifa
    Samuelsz, Errin
    Chen, Inna
    Collisson, Eric A.
    Calatayud, Dan
    Jensen, Benny V.
    Hasselby, Jane Preuss
    Lu, Timothy T.
    Poole, Jason C.
    Melnikova, Vlada
    Erlander, Mark G.
    CANCER RESEARCH, 2015, 75
  • [39] Mutant KRAS in Circulating Tumor DNA Assessed by Digit Droplet PCR as a Biomarker in Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy
    Vitello, Dominic
    Shah, Dhavan
    Wells, Amy
    Masnyk, Larissa
    Cox, Madison
    Janczewski, Lauren
    Abad, John
    Dawravoo, Kevin
    D'Souza, Arlene
    Suh, Grace
    Bayer, Robert
    Cristofanilli, Massimo
    Bentrem, David
    Liu, Yingzhe
    Zhang, Hui
    Santana-Santos, Lucas
    Jennings, Lawrence
    Zhang, Qiang
    Chawla, Akhil
    CANCER RESEARCH, 2024, 84 (17)
  • [40] Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
    Earl, Julie
    Garcia-Nieto, Sandra
    Carlos Martinez-Avila, Jose
    Montans, Jose
    Sanjuanbenito, Alfonso
    Rodriguez-Garrote, Mercedes
    Lisa, Eduardo
    Mendia, Elena
    Lobo, Eduardo
    Malats, Nria
    Carrato, Alfredo
    Guillen-Ponce, Carmen
    BMC CANCER, 2015, 15